Skip to main content

MoneyWorks4Me

Laurus Labs informs about board meeting

20 Oct 2021 Evaluate
Laurus Labs has informed that the meeting of the Board of Directors of the Company is scheduled on 28/10/2021 to consider and approve the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2021; to consider the proposal for payment of Interim Dividend for FY 2021-22 and fixation of record date for determining the eligibility of shareholders (if approved).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1825.35
Dr. Reddys Labs. 1360.80
Cipla 1401.75
Lupin 1987.50
Zydus Lifesciences 1196.40
View more..